Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.
Circ J. 2020 May 25;84(6):1012-1019. doi: 10.1253/circj.CJ-19-1071. Epub 2020 Mar 27.
Although left bundle-branch block (LBBB) is a known conduction disorder that occurs after transcatheter aortic valve implantation (TAVI), its clinical impact in the Japanese population remains unclear.
Of the 298 consecutive patients who underwent TAVI from January 2016 to December 2018 in a high-volume center in Japan, 68 with prior or periprocedural permanent pacemaker implantation (PPI), pre-existing LBBB, death during hospitalization, aborted procedure, or incomplete data were excluded. Among the final cohort of 230 patients, new-onset LBBB occurred in 90 (39%) after TAVI and persisted at 1-month follow up in 29 patients (13%; persistent new-onset LBBB, PN-LBBB). On multivariable analysis, self-expandable valve (SEV) use was found to be the only predictor of PN-LBBB (odds ratio: 4.39, 95% confidence interval: 1.69-11.41, P=0.002). There were no differences between patients with and without PN-LBBB in terms of overall mortality (18.8% vs. 26.0%, log-rank P=0.90) or need for late PPI (4.0% vs. 3.5%, log-rank P=0.74), yet there was an increased re-admission rate for heart failure (HF) in the PN-LBBB group (15.6% vs. 8.0%, log-rank P=0.046) at a median follow up of 431 (interquartile range, 271-733) days.
PN-LBBB following TAVI was not associated with mortality or late PPI, but with a higher incidence of HF-related re-hospitalization at the mid-term follow up.
尽管左束支传导阻滞(LBBB)是经导管主动脉瓣植入(TAVI)后已知的传导障碍,但在日本人群中的临床影响尚不清楚。
在日本一家大容量中心,2016 年 1 月至 2018 年 12 月期间,对 298 例连续接受 TAVI 的患者进行了研究,其中 68 例患者因先前或围手术期永久性起搏器植入(PPI)、预先存在的 LBBB、住院期间死亡、手术失败或数据不完整而被排除在外。在最终的 230 例患者队列中,90 例(39%)在 TAVI 后出现新发 LBBB,29 例(13%;持续性新发 LBBB,PN-LBBB)在 1 个月随访时仍存在。多变量分析发现,自膨式瓣膜(SEV)的使用是 PN-LBBB 的唯一预测因素(比值比:4.39,95%置信区间:1.69-11.41,P=0.002)。在总体死亡率(18.8% vs. 26.0%,log-rank P=0.90)或晚期 PPI 的需求(4.0% vs. 3.5%,log-rank P=0.74)方面,PN-LBBB 患者与无 PN-LBBB 患者之间无差异,但 PN-LBBB 组因心力衰竭(HF)再入院率较高(15.6% vs. 8.0%,log-rank P=0.046),中位随访时间为 431(四分位间距,271-733)天。
TAVI 后出现 PN-LBBB 与死亡率或晚期 PPI 无关,但在中期随访中与 HF 相关的再住院率较高有关。